Schering-Plough Corporation
Overview
Schering-Plough Corporation was a global pharmaceutical company known for its research and development activities in various therapeutic areas. It became a subsidiary of Merck & Co., Inc. in 2009 following a merger, expanding Merck's portfolio in several therapeutic areas.
Therapeutic areas
API / Drug Master Files
Schering-Plough Corporation holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES.Inactive1982-05-25
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Schering-Plough Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Schering-Plough Corporation? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.